MSH2 and neurofibromatosis type 1: Comparing NF1 patients with a low number of cutaneous neurofibromas to those with a high number of cutaneous neurofibromas, using methylation-specific PCR and pyrosequencing, indicated that the promoter methylation of the mismatch repair MSH2 gene in the blood cells of patients was significantly different (43).